Leprosy cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Cost-effectiveness of Therapy== | ==Cost-effectiveness of Therapy== | ||
In 1990, the [[WHO]] defined a goal of eliminating leprosy as a [[public health]] issue within 10 years. Between the years of 1985 and 2010, the number of registered cases of leprosy fell from 5.4 million to 244,796, with [[prevalence]] rate per 10,000 falling from 21,1 to 0.37. | |||
==References== | ==References== | ||
Revision as of 18:03, 6 July 2014
|
Leprosy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Leprosy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Leprosy cost-effectiveness of therapy |
|
Risk calculators and risk factors for Leprosy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Cost-effectiveness of Therapy
In 1990, the WHO defined a goal of eliminating leprosy as a public health issue within 10 years. Between the years of 1985 and 2010, the number of registered cases of leprosy fell from 5.4 million to 244,796, with prevalence rate per 10,000 falling from 21,1 to 0.37.